Integra LifeSciences Holdings EBITDA 2010-2025 | IART
Integra LifeSciences Holdings Annual EBITDA (Millions of US $) |
|
---|---|
2024 | $175 |
2023 | $241 |
2022 | $364 |
2021 | $324 |
2020 | $295 |
2019 | $209 |
2018 | $228 |
2017 | $136 |
2016 | $191 |
2015 | $141 |
2014 | $117 |
2013 | $69 |
2012 | $129 |
2011 | $108 |
2010 | $139 |
2009 | $140 |
Integra LifeSciences Holdings Quarterly EBITDA (Millions of US $) |
|
---|---|
2025-06-30 | $-473 |
2025-03-31 | $23 |
2024-12-31 | $75 |
2024-09-30 | $29 |
2024-06-30 | $35 |
2024-03-31 | $36 |
2023-12-31 | $68 |
2023-09-30 | $59 |
2023-06-30 | $45 |
2023-03-31 | $69 |
2022-12-31 | $99 |
2022-09-30 | $96 |
2022-06-30 | $91 |
2022-03-31 | $78 |
2021-12-31 | $91 |
2021-09-30 | $88 |
2021-06-30 | $83 |
2021-03-31 | $62 |
2020-12-31 | $85 |
2020-09-30 | $98 |
2020-06-30 | $49 |
2020-03-31 | $63 |
2019-12-31 | $65 |
2019-09-30 | $8 |
2019-06-30 | $74 |
2019-03-31 | $61 |
2018-12-31 | $63 |
2018-09-30 | $54 |
2018-06-30 | $57 |
2018-03-31 | $54 |
2017-12-31 | $35 |
2017-09-30 | $32 |
2017-06-30 | $39 |
2017-03-31 | $30 |
2016-12-31 | $60 |
2016-09-30 | $49 |
2016-06-30 | $41 |
2016-03-31 | $41 |
2015-12-31 | $43 |
2015-09-30 | $27 |
2015-06-30 | $37 |
2015-03-31 | $34 |
2014-12-31 | $43 |
2014-09-30 | $23 |
2014-06-30 | $28 |
2014-03-31 | $23 |
2013-12-31 | $59 |
2013-09-30 | $-19 |
2013-06-30 | $19 |
2013-03-31 | $10 |
2012-12-31 | $33 |
2012-09-30 | $34 |
2012-06-30 | $32 |
2012-03-31 | $31 |
2011-12-31 | $21 |
2011-09-30 | $32 |
2011-06-30 | $24 |
2011-03-31 | $31 |
2010-12-31 | $35 |
2010-09-30 | $37 |
2010-06-30 | $34 |
2010-03-31 | $32 |
2009-12-31 | $41 |
2009-09-30 | $34 |
2009-06-30 | $33 |
2009-03-31 | $32 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $1.156B | $1.611B |
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $184.932B | 22.37 |
Intuitive Surgical (ISRG) | United States | $169.861B | 70.41 |
IDEXX Laboratories (IDXX) | United States | $51.765B | 53.87 |
Edwards Lifesciences (EW) | United States | $47.690B | 31.61 |
Alcon (ALC) | Switzerland | $39.183B | 26.31 |
IQVIA Holdings (IQV) | United States | $32.084B | 18.13 |
DexCom (DXCM) | United States | $29.443B | 44.17 |
Mettler-Toledo (MTD) | United States | $26.431B | 31.37 |
STERIS (STE) | Ireland | $24.108B | 25.66 |
Waters (WAT) | United States | $17.717B | 24.34 |
SONOVA HOLDING (SONVY) | Switzerland | $17.161B | 0.00 |
Hologic (HOLX) | United States | $14.818B | 16.05 |
Penumbra (PEN) | United States | $10.595B | 77.40 |
Globus Medical (GMED) | United States | $8.256B | 19.04 |
Sysmex ADR (SSMXY) | Japan | $8.070B | 25.64 |
Masimo (MASI) | United States | $7.657B | 25.77 |
Teleflex (TFX) | United States | $5.578B | 9.00 |
Glaukos (GKOS) | United States | $5.538B | 0.00 |
TransMedics (TMDX) | United States | $3.979B | 60.48 |
Integer Holdings (ITGR) | United States | $3.762B | 18.77 |
LivaNova (LIVN) | United Kingdom | $3.028B | 17.33 |
Alphatec Holdings (ATEC) | United States | $2.372B | 0.00 |
Veracyte (VCYT) | United States | $2.356B | 32.55 |
PROCEPT BioRobotics (PRCT) | United States | $2.244B | 0.00 |
Artivion (AORT) | United States | $2.067B | 104.31 |
Nihon Kohden (NHNKY) | Japan | $1.940B | 23.16 |
Elekta AB (EKTAY) | Sweden | $1.806B | 17.50 |
OPKO Health (OPK) | United States | $1.127B | 0.00 |
Pulse Biosciences (PLSE) | United States | $1.047B | 0.00 |
IRadimed (IRMD) | United States | $0.929B | 45.07 |
Beta Bionics (BBNX) | United States | $0.813B | 0.00 |
Tandem Diabetes Care (TNDM) | United States | $0.797B | 0.00 |
AxoGen (AXGN) | United States | $0.746B | 0.00 |
SiBone (SIBN) | United States | $0.717B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.582B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.551B | 9.73 |
OrthoPediatrics (KIDS) | United States | $0.538B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.467B | 0.00 |
Semler Scientific (SMLR) | United States | $0.453B | 3.64 |
AngioDynamics (ANGO) | United States | $0.412B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
Delcath Systems (DCTH) | United States | $0.381B | 90.67 |
RxSight (RXST) | United States | $0.374B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.371B | 9.43 |
Spectral Diagnostics (EDTXF) | Canada | $0.305B | 0.00 |
NeuroPace (NPCE) | United States | $0.301B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.294B | 20.26 |
Alpha Tau Medical (DRTS) | Israel | $0.285B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.235B | 0.00 |
Neuronetics (STIM) | United States | $0.227B | 0.00 |
908 Devices (MASS) | United States | $0.224B | 0.00 |
Inogen (INGN) | United States | $0.215B | 0.00 |
Sight Sciences (SGHT) | United States | $0.212B | 0.00 |
CVRx (CVRX) | United States | $0.206B | 0.00 |
Microbot Medical (MBOT) | United States | $0.182B | 0.00 |
Accuray (ARAY) | United States | $0.176B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.155B | 0.00 |
LENSAR (LNSR) | United States | $0.145B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.130B | 0.00 |
Anteris Technologies Global (AVR) | Australia | $0.130B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.111B | 0.00 |
InspireMD (NSPR) | United States | $0.101B | 0.00 |
Hyperfine (HYPR) | United States | $0.097B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.097B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.083B | 0.00 | |
QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
Spectral AI (MDAI) | United States | $0.053B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
Precision Optics (POCI) | United States | $0.038B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
Envoy Medical (COCH) | United States | $0.026B | 0.00 |
DarioHealth (DRIO) | United States | $0.023B | 0.00 |
NexGel (NXGL) | United States | $0.020B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.017B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
Tenon Medical (TNON) | United States | $0.011B | 0.00 |
PAVmed (PAVM) | United States | $0.010B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
Nuwellis (NUWE) | United States | $0.005B | 0.00 |
Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
Venus Concept (VERO) | Canada | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.30 |